Bankers in their twenties suffering more heart attacks, doctors warn
These unlikely patients regularly present themselves with two types of heart conditions: cardiac arrhythmia and myocarditis. (Source: the Mail online | Health)
Source: the Mail online | Health - August 6, 2018 Category: Consumer Health News Source Type: news

Have We Reached the Point of Primary Prevention for AF? Have We Reached the Point of Primary Prevention for AF?
Should we offer primary prevention therapy for patients at risk of atrial fibrillation, even before the arrhythmia has occurred? What are the risks, and which patients would benefit?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Heart arrhythmia symptoms: Speak to your doctor if you feel this in your chest
HEART arrhythmia symptoms depend on what variation of the condition you have, but there are five common signs associated with all abnormal heart rhythms. One is a particular feeling in your chest. (Source: Daily Express - Health)
Source: Daily Express - Health - July 30, 2018 Category: Consumer Health News Source Type: news

The future of Abbott ’ s electrophysiology business
At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Check out his keynote address with DeviceTalks founder Brian Johnson. To learn more from the brightest minds in medtech, don’t miss DeviceTalks Boston on Oct. 8-10 The post The future of Abbott’s electrophysiology business appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Cardiovascular DeviceTalks Q&A Wall Street Beat Abbott DeviceTalks Boston DeviceTalks Minnesota Source Type: news

7 medtech stories we missed this week: July 27, 2018
[Image from unsplash.com]From the FDA clearing LifeSignal’s wireless ECG to Zavation receiving FDA clearance for its expandable corpectomy cage, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears LifeSignal’s wireless ECG LifeSignals announced in a July 26 press release that it has received FDA clearance for its wireless LP1100 Life Signal Patch. The patch is designed to be used in wearables and healthcare monitoring devices. The clearance allows the company to use the Life Signal Processor to develop ECG and other vital sign monitoring wearables ...
Source: Mass Device - July 27, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Prosthetics Regulatory/Compliance DoseOptics FBC Device Flashback Technologies Health.io LifeSignal Medi-Lynx Cardiac Monitoring MedTe Source Type: news

This engineered heart ventricle helps with studying arrhythmia and cardiomyopathy
[Luke MacQueen and Michael Rosnach/Harvard University]While engineered heart tissues can replicate muscle contraction and electrical activity in a dish, many aspects of heart disease can only adequately be captured in 3D. In a report published online yesterday by Nature Biomedical Engineering, researchers describe a scale model of a heart ventricle, built to replicate the chamber’s architecture, physiology and contractions. Cardiac researchers at Boston Children’s Hospital think it could help them find treatments for congenital heart diseases. Building a 3D engineered heart ventricle Collaborators from the Harv...
Source: Mass Device - July 26, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Vector Blog Source Type: news

Deaths linked to heat set to rise sharply
MPs warn heat-related deaths could treble by 2050 Related items fromOnMedica Cold snap has immediate effect on emergency admissions Particulate levels linked to arrhythmias and embolisms Poor patients more likely to die after heart surgery than rich Active elderly live independently and avoid social care Volume of exercise in older men more beneficial than duration (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 26, 2018 Category: UK Health Source Type: news

A 3D model of a human heart ventricle
(Harvard John A. Paulson School of Engineering and Applied Sciences) Harvard University researchers have bioengineered a three-dimensional model of a human left heart ventricle that could be used to study diseases, test drugs and develop patient-specific treatments for heart conditions such as arrhythmia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 23, 2018 Category: International Medicine & Public Health Source Type: news

A 3-D model of a human heart ventricle
(Harvard John A. Paulson School of Engineering and Applied Sciences) Harvard University researchers have bioengineered a three-dimensional model of a human left heart ventricle that could be used to study diseases, test drugs and develop patient-specific treatments for heart conditions such as arrhythmia. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 23, 2018 Category: Biology Source Type: news

Google executive Heidi Dohse on becoming a heart patient
For more than 30 years, Google (NSDQ:GOOG) executive Heidi Dohse has been fully dependent on pacemakers to help power her heart. But that hasn’t stopped her from becoming a competitive cyclist, competing in events around the world. At DeviceTalks Minnesota, Dohse spoke with Randall Shiestl, VP of R&D at Boston Scientific‘s (NYSE:BSX) global technology unit, about her journey through the healthcare system and into the world of medical technology after she was diagnosed with a rare arrhythmia in 1983. Now on her seventh pacemaker, Dohse shared her story of learning to trust the medical devices that keep ...
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiac Implants Boston Scientific Google Inc. Source Type: news

New Cochrane health evidence challenges belief that omega 3 supplements reduce risk of heart disease, stroke or death
New evidence published today shows there is little or no effect of omega 3 supplements on our risk of experiencing heart disease, stroke or death.Omega 3 is a type of fat. Small amounts of omega 3 fats are essential for good health, and they can be found in the food that we eat. The main types of omega 3 fatty acids are; alpha ­linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).  ALA is normally found in fats from plant foods, such as nuts and seeds (walnuts and rapeseed are rich sources). EPA and DHA, collectively called long chain omega 3 fats, are naturally found in fatty fish, su...
Source: Cochrane News and Events - July 16, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, the Bedford, Mass.-based company said. “With the recent strategic partnership NinePoint entered into with Merit Medical, along with Eman’s long history with the technology, business acumen, and strong leadership, this was a natural choice for the Board and a great next...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Alfred Mann Foundation Bonesupport Cutera Inc. Endologix GE Healthcare iRhythm Technologies Inc. Merit Medical Systems Inc. NinePoint Medical Inc. personnel-moves RTI Surgical SeaSpine second-sight-medical Source Type: news

Treating AFib with ablation reduces mortality and stroke
(University of California - Davis Health System) Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new research from UC Davis physicians shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news

Weight Loss May Reverse Course of Atrial Fibrillation
THURSDAY, June 28, 2018 -- Weight loss might help reverse progression of a common heart arrhythmia in obese adults, a new study shows. Researchers found that when obese adults with atrial fibrillation (a-fib) shed at least 10 percent of their... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2018 Category: General Medicine Source Type: news

For Pediatric Patients, Wearable Cardioverter Defibrillator Safe
TUESDAY, June 26, 2018 -- For pediatric patients with ventricular arrhythmias at risk for sudden cardiac death (SCD), a wearable cardioverter defibrillator (WCD) seems safe and effective, according to a review published online June 26 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 26, 2018 Category: Pharmaceuticals Source Type: news

Johnson & Johnson hits the Big Apple with latest JLabs site
Johnson & Johnson (NYSE:JNJ) opened its latest life science incubator in New York City, the healthcare giant said today. The 30,000-square-foot JLabs @ NYC is a collaboration between Johnson & Johnson Innovation, New York State and the New York Genome Center. Sited at the genome center in SoHo, the incubator is home to 26 startups and has room for four more, New Brunswick, N.J.-based J&J said. “Johnson & Johnson has deep entrepreneurial roots in New York and we are pleased to see our unique JLabs model applied in this rich ecosystem to foster the creation of new healthcare innovations that have t...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Research & Development johnsonandjohnson Source Type: news

Acute cyanide poisoning: are skin findings and odors helpful in making the diagnosis?
2 out of 5 stars Challenges in the diagnosis of acute cyanide poisoning. Parker-Cote JL et al. Clin Toxicol 2018;56(7):609-617 Abstract The stated goal of this somewhat confusing and unfocused article was to “identify isolated acute cyanide poison cases and to identify reported signs, symptoms and laboratory findings.” The authors did a systematic literature review to retrieve cases reports and case series describing patients who were alive on presentation after acute exposure to a cyanide salt. Patients exposed to cyanide in association with smoke inhalation were excluded. They found 65 relevant studies (...
Source: The Poison Review - June 19, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical bitter almond odor cherry red skin clinical characteristics cyanide poisoning ingestion Source Type: news

Philips acquires Remote Diagnostic Technologies
Royal Philips (NYSE:PHG) said today it acquired U.K.-based Remote Diagnostic Technologies for an undisclosed amount. Remote Diagnostic Technologies develops cardiac therapy, data management and monitoring solutions for the pre-hospital market, and has a portfolio of connected emergency care solutions that Amsterdam-based Philips said will complement its therapeutic care biz. “We are committed to investing in and expanding our resuscitation and emergency care offering, and with the acquisition of RDT we can boost our capabilities and portfolio in this vital area of healthcare. With its focus on the pre-hospi...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Patient Monitoring royalphilips Source Type: news

Medical News Today: 24-hour Holter monitoring: What to know
A Holter monitor is a medical device that can help to diagnose heart problems, such as arrhythmias. A technician will attach electrodes to a person ’s chest, and the person will wear the monitor for 24 hours. In this article, learn what to expect, how to wear the monitor properly, and what results mean. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 15, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Philips to acquire EPD solutions in $293m upfront deal
Royal Philips (NYSE:PHG) said today it inked a deal to acquire image-guided cardiac arrhythmia treatment dev EPD Solutions for $293 million (EU €250 million) upfront with a possible additional $246.2 million (EU €210 million) upon completion of the deal based on certain milestones. EPD Solutions produces cardiac imaging and navigation systems designed to aid electrophysiologists in navigating the heart through a detailed 3D image of the cardiac anatomy, Amsterdam-based Philips said. The system is also designed to identify the location and orientation of catheters during the diagnostic and therapeutic pr...
Source: Mass Device - June 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Mergers & Acquisitions royalphilips Source Type: news

Philips Bets Big on Image-Guided Therapy with Latest Acquisition
Royal Philips is seeking to expand its image-guided therapy solutions with the acquisition EPD Solutions. Philips is set to acquire the Tortola, British Virgin Islands-based company for about $292 million upfront. The deal could close in July, Philips said. EPD’s cardiac imaging and navigation system has received CE mark and is used in diagnostic and therapeutic procedures for cardiac arrhythmias. The system has not been given a nod from FDA and is currently under review by the agency. Philips said its interventional imaging systems, such as Azurion, and EPD’s cardiac imaging and navigation system could more ef...
Source: MDDI - June 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Cardiovascular Source Type: news

Medical News Today: Is a tickle in the chest serious?
A tickle in the chest has many possible causes. Colds and seasonal allergies are often behind this symptom, but it can also result from conditions such as anxiety, acid reflux, and arrhythmia. In this article, learn about the range of causes and how to tell if a tickle in the chest is serious enough to need treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 4, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

LuxCath eyes the atrial fibrillation market
One problem with using ablation to treat atrial fibrillation is determining when the resulting lesion is sufficient to block the electric signals underlying the arrhythmia. LuxCath thinks its OmniView catheter solves the dilemma by using an optical technology to assess metabolic activity in the ablated tissue, CEO Dr. Omar Amirana told MassDevice.com earlier this month during the annual Heart Rhythm Society meeting in Boston. Amirana, a senior vice president at Allied Minds (LON:ALM), also helms Allied Minds subsidiaries SciFluor and Signature Medical and is a board member at CardioFocus. What drew him to LuxCath, he ...
Source: Mass Device - May 29, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Catheters Wall Street Beat Allied Minds LuxCath LLC Source Type: news

A case of life-threatening loperamide toxicity
3 out of 5 stars Severe loperamide toxicity associated with the use of cimetidine to potentiate the “high.” Hughes A et al. AM J Emerg Med 2018 May 15 [Epub ahead of print] Reference The potential adverse effects of loperamide (Imodium) are often underestimated since, even though it is an opioid, it is available over-the-counter and has been since 1988. Loperamide is used to treat diarrhea. It acts on the mu-opioid receptors in the gut, decreasing gastric motility. It is rather effective at this. However at therapeutic doses (2-16 mg per day) it does not cause central opioid effects such as euphoria or rel...
Source: The Poison Review - May 24, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical imodium loperamide overdose toxicity Source Type: news

Morbidity in Pregnancy Common for Women With Heart Disease
WEDNESDAY, May 23, 2018 -- For women with heart disease, cardiac complications occur in 16 percent of pregnancies and are mainly linked to arrhythmias and heart failure, according to a study published in the May 29 issue of the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2018 Category: Pharmaceuticals Source Type: news

An Egg A Day Might Reduce Your Risk Of Heart Disease, Study Says
In this study however, they didn’t assess the risk of developing diabetes, which may be because diabetes is a newer disease in the Chinese population and there is not good documentation of who has it,” Richard said. Still, she noted, “this will be very important data for helping develop dietary prevention guidelines in China.” Cardiovascular disease, which takes the lives of 17.7 million people every year, is the leading cause of death and disability worldwide, according to the World Health Organization. Cardiovascular disease causes nearly a third — 31% — of all global deaths each year....
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Eggs Heart Disease Local TV Source Type: news

Software Co. Combines AI and Wearables For Glucose Monitoring
Artificial Intelligence (AI), wearables, and diabetes monitoring are arguably three of the hottest sectors in medtech at the moment. LifePlus, a small software startup, has the distinction of belonging to all three markets. The Menlo, CA-based company is developing LifeLeaf, a non-invasive continuous blood glucose monitoring (CGM) multi-sensor wearable device that uses AI. The device is currently involved in five clinical trials across the world. “We’re a young company that has been in stealth mode for almost three years working on this problem,” John Trobough, chairman and CEO of LifePlus, told MD+D...
Source: MDDI - May 16, 2018 Category: Medical Devices Authors: Omar Ford Tags: Software Source Type: news

Why new battery technology will lead to disruptive medtech innovations
What’s the next big disruption in battery technology? Three experts from Integer, a global leader in medical device outsourcing, weigh in. Martin Cholette, Robert Rubino and Chris Williams, Integer A cut-out view of a cylindrical leadless pacemaker battery. [Image courtesy of Integer] What new technologies in medtech are being enabled by advances in battery technology? Chris Williams: One new technology is the leadless cardiac pacing market. Integer has developed batteries in a cylindrical form that allows for implants through the femoral vein in a minimally invasive procedure. Applications for energy storage c...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Contract Manufacturing mHealth (Mobile Health) Research & Development integer Source Type: news

Boston Scientific touts safety, effectiveness in Rhythmia mapping study
Boston Scientific‘s (NYSE:BSX) Rhythmia mapping system and catheter was found to be safe and effective in procedures to treat arrhythmias, according to a Healio summary of a newly released study from the company. Researchers in the study examined 572 patients, with 519 patients undergoing procedures with the Rhythmia system and IntellaMap Orion catheter, according to the report. A total of 504 patients had a complete mapping procedure and were followed for one month post-procedure. Findings from the study were presented at the EHRA 2018 meeting, according to Healio. The primary endpoint of the trial was acute procedu...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Imaging Boston Scientific Source Type: news

HRS 2018 Roundup: Researchers highlight the latest in cardiac ablation tech
There are lots of new opportunities in ablation, evidenced by the research touted at this year’s annual meeting of the Heart Rhythm Society in Boston. Scientists presented data from trials evaluating cardiac ablation via pulsed electric fields, intramural needle ablation and more. Editors at MassDevice.com asked leading cardiac electrophysiologist Dr. Vivek Reddy, will there someday be one catheter to rule them all? “As in most things, there will always be several,” he explained. Here’s a look at some of the ablation technology presented at this year’s meeting. Intramural needle abla...
Source: Mass Device - May 14, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Wall Street Beat BioSense Webster Inc. Boston Scientific johnsonandjohnson Medtronic Source Type: news

Medical News Today: What causes the heart to skip a beat?
While feeling like the heart has skipped a beat can be frightening, it is a common experience and not usually a cause for concern. In this article, learn why a person has heart palpitations. We explore the roles of anxiety, arrhythmias, medications, hormones, and lifestyle factors. We also discuss when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 13, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Heart Botox Injections Durably Protect from Arrhythmia in Pilot Trial
(MedPage Today) -- Effect persisted to 3 years in small trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 12, 2018 Category: Cardiology Source Type: news

Stroke risk remains high for thousands of patients with 'resolved' AF
Hundreds of thousands of patients with 'resolved' atrial fibrillation (AF) remain at high risk of stroke and should continue to be prescribed anticoagulants, researchers have warned. (Source: GP Online News)
Source: GP Online News - May 11, 2018 Category: Primary Care Tags: Arrhythmias Source Type: news

AI a Natural Fit For Cardiovascular Diagnostics
Bardy Diagnostics is developing an artificial intelligence-enabled (AI) screening technology to detect atrial fibrillation (Afib) events. The company presented a poster with data validating the AI strategy at the 39th annual Heart Rhythm Society (HRS). Data from the poster showed the Seattle-based company’s detection technology's validated sensitivity was 95% and the specificity was 91% for an Afib event spanning 10 minutes or longer. Rodney Boleyn is the lead author of the poster research presented at HRS. Boleyn is also a senior software engineer at Bardy. “It’s always been a question of what part of th...
Source: MDDI - May 9, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Murj Makes ICD Data More Manageable
Murj, a software solutions company, has developed a cloud-based platform that has the potential to make it easier for hospitals and healthcare facilities to track data coming from implantable cardiac devices (ICDS). The Santa Cruz, CA-based company has raised $8.5 million in a series B round. The financing will be used to expand  Murj’s salesforce and marketing efforts for the cloud-based platform. The series B round brings Murj’s funding to nearly $14 million since inception, said Todd Butka, the company’s founder and CEO. Murj’s solution was on display at the Heart Rhythm Society’s annu...
Source: MDDI - May 9, 2018 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Software Source Type: news

Gene therapy prevents heart arrhythmia in test with mice
A simple single gene-editing approach may help prevent prevent heart arrhythmia -- abnormal heartbeats -- in mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 9, 2018 Category: Consumer Health News Source Type: news

Marijuana Use Not Linked to Risk of Arrhythmias After Acute MI
WEDNESDAY, May 9, 2018 -- For patients with acute myocardial infarction (AMI), marijuana use is not associated with increased risk of ventricular tachycardia/ventricular fibrillation (VT/VF) or cardiac arrest, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2018 Category: Pharmaceuticals Source Type: news

New Cardiac Mapping Options for Complex Arrhythmias
  CARLSBAD, Calif., May 8, 2018 /PRNewswire/ -- Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment ablation procedures in Europe and Canada.   "Enabling physicians to see complex, irregular arrhythmias in real-time should provide important new insights and enable truly personalized and individualized abla...
Source: MDDI - May 9, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Imaging Source Type: news

New gene therapy sparks healthy heart beats
(Cornell University) Michael Kotlikoff, provost of Cornell University and a professor of molecular physiology, is part of an international collaboration that is aiming to prevent heart arrhythmias with a simple gene-therapy approach. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

Acutus Medical launches AcQMap cardiac mapping tech in US
Acutus Medical said today it launched the AcQMap high-resolution imaging & mapping system and the 3D mapping catheter that goes by the same name, touting that the system had been used in its first commercial procedures. The Carlsbad, Calif.-based company said that AcQMap system is designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. “Enabling physicians to see complex, irregular arrhythmias in real-time should provide important new insights and enable truly personalized and individua...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Catheters Imaging Acutus Medical Inc. Source Type: news

All heart: A Google executive ’ s real-world experience with medtech
Heidi Dohse, senior program manager at Google After hearing the story of her 10 cardiac surgeries and seven pacemakers, you could be forgiven for thinking that Heidi Dohse has a weak heart. But the Google executive, endurance cyclist and, now, inspirational speaker she may have a stronger heart than most people on the planet. Dohse, a senior program manager at Google and upcoming keynote speaker at DeviceTalks Minnesota, was 18 when an EKG before a routine knee surgery to clean out scar tissue, which had built up during her days as a competitive skier and professional windsurfer, uncovered a rare and potentially deadly arr...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Brian Johnson Tags: Business/Financial News Cardiovascular DeviceTalks Q&A devicetalksminnesota google Google Inc. Source Type: news

CardioFocus wins FDA nod for HeartLight AF balloon
CardioFocus said today it won FDA approval for its HeartLight Excalibur balloon designed to treat paroxysmal atrial fibrillation. The Marlborough, Mass.-based company said that the newly cleared balloon uses technology from its HeartLight endoscopic ablation system alongside a new feature set intended to improve speed and magnitude of tissue contact during pulmonary vein isolation procedures. “We have seen encouraging results with the Excalibur Balloon. It obtains an impressive antral position and establishes even more tissue contact, which enables contiguous lesion sets. This is a clear advance in the field of ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance CardioFocus Inc. Source Type: news

Abbott wins FDA nod for Advisor HD Gridcardiac mapping cath
Abbott (NYSE:ABT) said today it won FDA clearance for is Advisor HD Grid mapping sensor enabled catheter designed for creating highly detailed maps of the heart. The newly cleared mapping catheter builds on the Abbott Park, Ill.-based company’s previous designs and and is intended to improve cardiac ablation procedures by providing an inside view of the heart for more accurate identification of the cardiac anatomy. The Advisor HD Grid catheter is designed to capture data including the direction and speed of cardiac signals, and allows for the creation of high-density maps of cardiac tissue for more optimal ...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
ADVISOR™ HD GRID MAPPING CATHETER, SENSOR ENABLED™ FACILITATES IMPROVED DATA COLLECTION, SUPPORTING OPTIMAL TREATMENT FOR PATIENTS WITH COMPLEX CARDIAC ARRHYTHMIAS FIRST-OF-ITS-KIND GRID CONFIGURATION IS DESIGNED TO CAPTURE DATA IN MULTIPLE DIRECTIONS T... Devices, Cardiology, FDA Abbott, Advisor, HD Grid Mapping Catheter, Arrhythmia, electrophysiology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 3, 2018 Category: Pharmaceuticals Source Type: news

For this Abbott executive, solving problems isn ’ t enough: ‘ We need to add value ’
As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore. What was your path like from electrical engineering to Abbott’s cardiac arrhythmia business? Pederson: As an engineer, I’ve always been drawn to how technology can evolve and re-shape entire industries. In particular, health technology can fundamentally change the lives of people battling complex health ...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Wall Street Beat Abbott devicetalksminnesota Source Type: news

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
- ADVISOR ™ HD GRID MAPPING CATHETER, SENSOR ENABLED™ FACILITATES IMPROVED DATA COLLECTION, SUPPORTING OPTIMAL TREATMENT FOR PATIENTS WITH COMPLEX CARDIAC ARRHYTHMIAS (Source: Abbott.com)
Source: Abbott.com - May 3, 2018 Category: Pharmaceuticals Source Type: news

Concerns Over Tick, Mosquito-Borne Diseases Rise After CDC Report
BOSTON (CBS) — A Center for Disease Control and Prevention (C.D.C.) report is raising concerns. From 2004-2016 the amount of tick, mosquito, and flea-transmitted diseases have tripled in the U.S. Nearly 60% of the diseases detected came from ticks. Dr. David Crandell, clinical co-director for the Dean Center Tick-Borne Illness at Spaulding Rehabilitation Hospital, says he’s not surprised. Dr. Crandell believes an increase in Lyme disease diagnosis comes from better testing and more importantly, a better understanding of the disease and the signs. He says symptoms include: Malaise, almost like a flu-like symptom...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 2, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local CDC Gary Brode Local TV Mosquitoes tick-borne disease ticks Source Type: news

Stroke Triage: EMS needs a diagnostic tool that goes beyond a simple history & physical exam
As a young EMT and paramedic, I had relatively little education about acute myocardial infarctions. In the age of the 3-lead ECG, education was largely focused on arrhythmia detection and how to differentiate heart blocks, tachycardia and bradycardia. Detection of heart attack was largely based upon history and physical exam findings. Three decades later, the thought of relying on a physical exam to diagnose a ST- elevation myocardial infarction (STEMI) is hard to imagine. Although we’ve made remarkable progress in the prehospital detection of STEMI, we’ve made significantly less progress in the diagnosis of ac...
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: Mark E.A. Escott, MD, MPH, FACEP, NRP Tags: Patient Care Columns Source Type: news

Substance in Chinese medicine can cause cardiac arrhythmia
(University of Basel) A medicinal plant frequently used in Traditional Chinese Medicine (TCM) -- Evodia rutaecarpa -- contains substances that can cause cardiac arrhythmia. This is what researchers from the Universities of Basel, Vienna and Utrecht have recently found out. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 2, 2018 Category: Biology Source Type: news